Characterization of a drug-resilient cancer cell phenotype.
Single cell sequencing of Poly aneuploid cancer cells in response to cisplatin treatment. In response to therapy these cells undergo whole genome doublings to survive. This was tested in HCC1806, 786-0, and PC3 cancer cells.